Discussing Challenges in mRNA Therapeutics with Phil Challis (INTERPHEX 2023)

Published on: April 25, 2023

Phil Challis, vice-president of product development at eTheRNA, discusses four of the major challenges in working with mRNA therapeutics.

Phil Challis, vice-president of product development at eTheRNA, discusses four of the major challenges in working with mRNA therapeutics. Some topics he touches on include; what makes a good RNA construct; making RNA more tolerable; storage and distribution of lipid nanoparticles; and more.

For more INTERPHEX 2023 video content, check this page for updates.